Joshua A. Boyce
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Joshua A. Boyce has a total of 265 co-authors. Here are the top co-authors by number of shared publications:
Chunli Feng
Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA; Jeff and Penny Vinik Center for Allergic Disease Research, Boston, MA
18 shared publicationsTao Liu
Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA; Jeff and Penny Vinik Center for Allergic Disease Research, Boston, MA; Department of Medicine, Harvard Medical School, Boston, MA
12 shared publicationsTanya M. Laidlaw
Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, USA
10 shared publicationsJuying Lai
Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, MA; Jeff and Penny Vinik Center for Allergic Disease Research, Boston, MA
9 shared publicationsK. Frank Austen
Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, and Departments of ‡Medicine and ¶Pediatrics, Harvard Medical School, Boston, MA 02115; §Partners Asthma Center, Boston, MA 02115; and †Department of Immunobiology and Inflammation, Millennium Pharmaceuticals, Inc., Cambridge, MA 02139
7 shared publicationsYoshihide Kanaoka
Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, USA
7 shared publications
Latest Publications
- 18 August 2026
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 158 (4) , 1157-1158
Reply
- 18 August 2026
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 158 (4) , 1157-1158
Reply
- Open Access
- 22 January 2026
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 157 (6) , 1365-1379
Platelet–macrophage cooperation drives IL-33–dependent type 2 lung immunopathology in a sex-biased manner
- 22 January 2026
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 157 (6) , 1365-1379
Open AccessPlatelet–macrophage cooperation drives IL-33–dependent type 2 lung immunopathology in a sex-biased manner
- Open Access
- 19 December 2025
- Published by Elsevier in Cell Reports
- Vol. 45 (1) , 116758
Mast cell-specific CysLT2 receptor signaling inhibits cysteinyl leukotriene-dependent mast cell activation and type 2 allergic lung inflammation
- 19 December 2025
- Published by Elsevier in Cell Reports
- Vol. 45 (1) , 116758
Open AccessMast cell-specific CysLT2 receptor signaling inhibits cysteinyl leukotriene-dependent mast cell activation and type 2 allergic lung inflammation
- Open Access
- 9 October 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (41)
Platelets engage mast cells in a bilateral IL-33-driven feed-forward loop
Platelets amplify type 2 inflammation (T2I) through incompletely understood mechanisms. Depletion of platelets markedly attenuated mast cell (MC) activation in a model of aspirin exacerbated respiratory disease (AERD) that depends on IL-33 and cysteinyl leukotrienes (cysLTs). We demonstrate an IL-33-driven feed-forward loop between platelets and MCs. IL-33 neutralization prevented increases in cysLTs and CXCL7, a platelet activation marker, in bronchoalveolar lavage (BAL) fluid from AERD-like mice in response to aspirin challenges. BAL fluid concentrations of PGD 2 correlated strongly with both CXCL7 and MC tryptase in subjects with severe asthma. Platelets amplified PGD 2 and LTC 4 productions by IL-33-stimulated mouse bone marrow–derived MCs (BMMCs), which induced release of CXCL7 and expression of CD62P by platelets. Deletions of MC-specific LTC 4 or platelet-specific type 2 cysLT receptor (CysLT 2 R) completely eliminated both platelet activation and the amplification of PGD 2 and LTC 4 generation by MCs. Platelet-derived ADP/ATP and MC-associated P2Y 1 receptors were essential. These findings identify an innate immune pathway involving MC–platelet interplay that may drive IL-33-dependent immunopathology in asthma.
- 9 October 2025
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (41)
Open AccessPlatelets engage mast cells in a bilateral IL-33-driven feed-forward loop
Platelets amplify type 2 inflammation (T2I) through incompletely understood mechanisms. Depletion of platelets markedly attenuated mast cell (MC) activation in a model of aspirin exacerbated respiratory disease (AERD) that depends on IL-33 and cysteinyl leukotrienes (cysLTs). We demonstrate an IL-33-driven feed-forward loop between platelets and MCs. IL-33 neutralization prevented increases in cysLTs and CXCL7, a platelet activation marker, in bronchoalveolar lavage (BAL) fluid from AERD-like mice in response to aspirin challenges. BAL fluid concentrations of PGD 2 correlated strongly with both CXCL7 and MC tryptase in subjects with severe asthma. Platelets amplified PGD 2 and LTC 4 productions by IL-33-stimulated mouse bone marrow–derived MCs (BMMCs), which induced release of CXCL7 and expression of CD62P by platelets. Deletions of MC-specific LTC 4 or platelet-specific type 2 cysLT receptor (CysLT 2 R) completely eliminated both platelet activation and the amplification of PGD 2 and LTC 4 generation by MCs. Platelet-derived ADP/ATP and MC-associated P2Y 1 receptors were essential. These findings identify an innate immune pathway involving MC–platelet interplay that may drive IL-33-dependent immunopathology in asthma.
- 11 January 2025
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 155 (5) , 1475-1477
The evolving prostaglandin E2 story in chronic sinus disease
- 11 January 2025
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 155 (5) , 1475-1477
The evolving prostaglandin E2 story in chronic sinus disease
- Open Access
- 2 January 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (1)
Human intraepithelial mast cell differentiation and effector function are directed by TGF-β signaling
Mast cells (MCs) expressing a distinctive protease phenotype (MC T s) selectively expand within the epithelium of human mucosal tissues during type 2 (T2) inflammation. While MC T s are phenotypically distinct from subepithelial MCs (MC TC s), signals driving human MC T differentiation and this subset’s contribution to inflammation remain unexplored. Here, we have identified TGF-β as a key driver of the MC T transcriptome in nasal polyps. We found that short-term TGF-β signaling alters MC cell surface receptor expression and partially recapitulated the in vivo MC T transcriptome, while TGF-β signaling during MC differentiation upregulated a larger number of MC T -associated transcripts. TGF-β inhibited the hallmark MC TC proteases chymase and cathepsin G at both the transcript and protein level, allowing selective in vitro differentiation of MC T s for functional study. We identified discrete differences in effector phenotype between in vitro–derived MC T s and MC TC s, with MC T s exhibiting enhanced proinflammatory lipid mediator generation and a distinct cytokine, chemokine, and growth factor production profile in response to both innate and adaptive stimuli, recapitulating functional features of their tissue-associated counterpart MC subsets. Thus, our findings support a role for TGF-β in promoting human MC T differentiation and identified a discrete contribution of this cell type to T2 inflammation.
- 2 January 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (1)
Open AccessHuman intraepithelial mast cell differentiation and effector function are directed by TGF-β signaling
Mast cells (MCs) expressing a distinctive protease phenotype (MC T s) selectively expand within the epithelium of human mucosal tissues during type 2 (T2) inflammation. While MC T s are phenotypically distinct from subepithelial MCs (MC TC s), signals driving human MC T differentiation and this subset’s contribution to inflammation remain unexplored. Here, we have identified TGF-β as a key driver of the MC T transcriptome in nasal polyps. We found that short-term TGF-β signaling alters MC cell surface receptor expression and partially recapitulated the in vivo MC T transcriptome, while TGF-β signaling during MC differentiation upregulated a larger number of MC T -associated transcripts. TGF-β inhibited the hallmark MC TC proteases chymase and cathepsin G at both the transcript and protein level, allowing selective in vitro differentiation of MC T s for functional study. We identified discrete differences in effector phenotype between in vitro–derived MC T s and MC TC s, with MC T s exhibiting enhanced proinflammatory lipid mediator generation and a distinct cytokine, chemokine, and growth factor production profile in response to both innate and adaptive stimuli, recapitulating functional features of their tissue-associated counterpart MC subsets. Thus, our findings support a role for TGF-β in promoting human MC T differentiation and identified a discrete contribution of this cell type to T2 inflammation.
- Open Access
- 17 June 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (12)
Defining and targeting mechanisms of eosinophilic inflammation in a new era of severe asthma treatment
Studies using mouse models of airway disease have advanced our understanding of the mechanisms driving eosinophilic airway inflammation and demonstrated potential therapeutic targets in asthma.
- 17 June 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (12)
Open AccessDefining and targeting mechanisms of eosinophilic inflammation in a new era of severe asthma treatment
Studies using mouse models of airway disease have advanced our understanding of the mechanisms driving eosinophilic airway inflammation and demonstrated potential therapeutic targets in asthma.
- 2 February 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 9 (92) , eabq4341
A nasal cell atlas reveals heterogeneity of tuft cells and their role in directing olfactory stem cell proliferation
The olfactory neuroepithelium serves as a sensory organ for odors and forms part of the nasal mucosal barrier. Olfactory sensory neurons are surrounded and supported by epithelial cells. Among them, microvillous cells (MVCs) are strategically positioned at the apical surface, but their specific functions are enigmatic, and their relationship to the other specialized epithelial cells is unclear. Here, we establish that the family of MVCs comprises tuft cells and ionocytes in both mice and humans. Integrating analysis of the respiratory and olfactory epithelia, we define the distinct receptor expression of TRPM5 + tuft-MVCs compared with Gɑ-gustducin high respiratory tuft cells and characterize a previously undescribed population of glandular DCLK1 + tuft cells. To establish how allergen sensing by tuft-MVCs might direct olfactory mucosal responses, we used an integrated single-cell transcriptional and protein analysis. Inhalation of Alternaria induced mucosal epithelial effector molecules including Chil4 and a distinct pathway leading to proliferation of the quiescent olfactory horizontal basal stem cell (HBC) pool, both triggered in the absence of olfactory apoptosis. Alternaria- and ATP-elicited HBC proliferation was dependent on TRPM5 + tuft-MVCs, identifying these specialized epithelial cells as regulators of olfactory stem cell responses. Together, our data provide high-resolution characterization of nasal tuft cell heterogeneity and identify a function of TRPM5 + tuft-MVCs in directing the olfactory mucosal response to allergens.
- 2 February 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 9 (92) , eabq4341
A nasal cell atlas reveals heterogeneity of tuft cells and their role in directing olfactory stem cell proliferation
The olfactory neuroepithelium serves as a sensory organ for odors and forms part of the nasal mucosal barrier. Olfactory sensory neurons are surrounded and supported by epithelial cells. Among them, microvillous cells (MVCs) are strategically positioned at the apical surface, but their specific functions are enigmatic, and their relationship to the other specialized epithelial cells is unclear. Here, we establish that the family of MVCs comprises tuft cells and ionocytes in both mice and humans. Integrating analysis of the respiratory and olfactory epithelia, we define the distinct receptor expression of TRPM5 + tuft-MVCs compared with Gɑ-gustducin high respiratory tuft cells and characterize a previously undescribed population of glandular DCLK1 + tuft cells. To establish how allergen sensing by tuft-MVCs might direct olfactory mucosal responses, we used an integrated single-cell transcriptional and protein analysis. Inhalation of Alternaria induced mucosal epithelial effector molecules including Chil4 and a distinct pathway leading to proliferation of the quiescent olfactory horizontal basal stem cell (HBC) pool, both triggered in the absence of olfactory apoptosis. Alternaria- and ATP-elicited HBC proliferation was dependent on TRPM5 + tuft-MVCs, identifying these specialized epithelial cells as regulators of olfactory stem cell responses. Together, our data provide high-resolution characterization of nasal tuft cell heterogeneity and identify a function of TRPM5 + tuft-MVCs in directing the olfactory mucosal response to allergens.
- Open Access
- 15 December 2023
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 208 (12) , 1346-1347
Reply to Li et al.
- 15 December 2023
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 208 (12) , 1346-1347
Open AccessReply to Li et al.